NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/04/2023
Back to search
Official data from USPTO
C CAMBRIDGE PHARMA AN SMC LTD. COMPANY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
04/04/2023
Trademark type
Combined
Nice classes
40
Filing date
05/15/2020
Registration date
04/04/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/04/2023
Last transaction
04/04/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/15/2021
First use in commerce
02/15/2021
Drawing code
3
Owner type
99
Owner location
Cambridge, GB
Examiner
DUBRAY, KATHERINE
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "CAMBRIDGE" in the color orange above the word "PHARMA" in the color grey that is above a line with the words "AN SMC LTD. COMPANY" below the line in the color grey next to a design of a stylized letter "C" in the color grey with a half circle design in the colors orange and white.
Holders and representatives
Holders
Cambridge Pharma Limited
Representatives
Michael T. Olsen WINTHROP & WEINSTINE, P.A.
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of pharmaceutical and biopharmaceutical preparations; custom assembly of pharmaceutical products; treatment of materials in the manufacture of pharmaceutical and biopharmaceutical preparationssterile filling of syringesauto-injectors and other medical instruments with pharmaceutical and biopharmaceutical preparations during manufacture excluding pharmaceutical research and development and drug discovery
Publications
History of USPTO decisions and trademark events.
51 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/25/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/24/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
01/16/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/08/2022
GNRT
NON-FINAL ACTION E-MAILED
09/08/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
09/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/19/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/18/2022
EX3G
SOU EXTENSION 3 GRANTED
08/18/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/16/2022
IUAF
USE AMENDMENT FILED
08/08/2022
EXT3
SOU EXTENSION 3 FILED
08/08/2022
EEXT
SOU TEAS EXTENSION RECEIVED
08/08/2022
EISU
TEAS STATEMENT OF USE RECEIVED
08/08/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/07/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/07/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/09/2022
EX2G
SOU EXTENSION 2 GRANTED
02/07/2022
EXT2
SOU EXTENSION 2 FILED
02/07/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/07/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/11/2021
EX1G
SOU EXTENSION 1 GRANTED
08/09/2021
EXT1
SOU EXTENSION 1 FILED
08/09/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/09/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/15/2020
PUBO
PUBLISHED FOR OPPOSITION
12/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/25/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/07/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
11/07/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/07/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
11/07/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/07/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/09/2020
GNRT
NON-FINAL ACTION E-MAILED
09/09/2020
CNRT
NON-FINAL ACTION WRITTEN
09/09/2020
DOCK
ASSIGNED TO EXAMINER
08/25/2020
DOCK
ASSIGNED TO EXAMINER
08/13/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/30/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/29/2020
NWAP
NEW APPLICATION ENTERED
05/19/2020
Continuous trademark protection
Get notified about every new filing that threatens C CAMBRIDGE PHARMA AN SMC LTD. COMPANY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.